Dalian BIO-CHEM Company Ltd Financials

Market Capitalization CN¥22.85 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	103.94
Forward PE	33.56
Price to Sales TTM	CN¥15.46
Price to Book MRQ	CN¥14.99
Enterprise to Revenue	15.98
Enterprise to EBITDA	64.02

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	14.68%
Operating Margin	17.03%
Return on Assets TTM	6.54%
Return on Equity TTM	12.74%

Income Statement

Revenue TTM	CN¥1,471,820,928
Revenue per Share TTM	CN¥2.10
Quarterly Revenue Growth	-1.80%
Gross Profit TTM	CN¥518,480,096
EBITDA	CN¥379,573,582
Net Income to Common TTM	CN¥216,030,928
Diluted EPS TTM	CN¥0.31
Quarterly Earnings Growth YoY	-77.20%

Balance Sheet

Total Cash MRQ	CN¥751,626,560
Total Cash per Share MRQ	CN¥1.07
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	53.87
Current Ratio MRQ	2.97
Book Value per Share MRQ	CN¥2.15

Cash Flow

Operating Cash Flow TTM	CN¥122,833,832
Levered Free Cash Flow TTM	CN¥-263,906,336

603360 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	706,223,654
Float Shares	262,310,181
Avg 10 Volume	10,158,716
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	60.26%
% Held by Institutions	2.18%

Stock Price Summary

Beta	0.26
Fifty Two Week Low	CN¥14.46
Fifty Two Week High	CN¥37.51
Fifty Two Week Change	53.45%
Day 50 MA	CN¥31.85
Day 200 MA	CN¥24.38

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.71
Forward Annual Dividend Yield	5.32%
Trailing Annual Dividend Rate	CN¥0.43
Trailing Annual Dividend Yield	1.33%
Payout Ratio	140.19%
Dividend Date
Ex Dividend Date	2025-05-29
Last Split Factor
Last Split Date	2025-05-29